Clinical Trial Update: Neoadjuvant Immunotherapy in Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant immunotherapy trial in adults with brain metastases was terminated; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Snippet

Sponsor: Sarah Sammons, MD | Conditions: Brain Metastases, Adult | Phase 2 | Status: TERMINATED | Results posted: 2022-07-26